A systematic review of all case-control studies investigating the association between the APOE gene and FTLD up to December 2011 was conducted. Case-control studies using clinical or pathological criteria for FTLD and reporting APOE allelic or genotypic data were included. Pooled odds ratios (ORs) were estimated using a random effects model, and 95% confidence intervals (CIs) were calculated.
Twenty-eight case-control studies met the inclusion criteria. Carriage of the 蔚2 allele had no effect on disease risk. On the contrary, carriage of the 蔚4 allele was associated with a significantly increased disease risk (蔚4 carriers vs non-蔚4 carriers: OR, 1.94; 95% CI, 1.43-2.64; 蔚4 vs 蔚3 allele:聽OR, 1.83; 95% CI, 1.34-2.52). Furthermore, a gene-dosage effect for the 蔚4 allele was found. There was no evidence of publication bias, but heterogeneity between the studies was high.
Our study provides evidence for an association between the APOE 蔚4 allele and frontotemporal lobar degeneration.